Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance

Haitao Li, Kangdong Liu, Lisa Allyn Boardman, Yuzhou Zhao, Lei Wang, Yuqiao Sheng, Naomi Oi, Paul John Limburg, Ann M. Bode, Zigang Dong

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Colorectal cancer (CRC) represents the third leading cause of cancer-related death in the United States. Lack of reliable biomarkers remains a critical issue for early detection of CRC. In this study, we investigated the potential predictive values of circulating prostaglandin (PG) biosynthesis in CRC risk. Methods: Profiles of circulating PG biosynthesis and platelet counts were determined in healthy subjects (n = 16), familial adenomatous polyposis (FAP) patients who were classified as regular aspirin users (n = 14) or nonusers (n = 24), and CRC patients with (n = 18) or without FAP history (n = 20). Immunohistochemistry staining was performed on biopsy samples. Results: Analysis of circulating PG biosynthesis unexpectedly revealed that CRC progression is accompanied by a pronounced elevation of circulating thromboxane A2 (TXA2) levels. When a circulating TXA2 level of 1000pg/mL was selected as a practical cutoff point, 95% of CRC patients were successfully identified. Further study suggested that the TXA2 pathway is constitutively activated during colorectal tumorigenesis and required for anchorage-independent growth of colon cancer cells. Conclusions: This study established the importance of the TXA2 pathway in CRC pathophysiology, and laid the groundwork for introducing a TXA2-targeting strategy to CRC prevention, early detection and management.

Original languageEnglish (US)
Pages (from-to)165-171
Number of pages7
JournalEBioMedicine
Volume2
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Thromboxane A2
Biosynthesis
Prostaglandins
Colorectal Neoplasms
Adenomatous Polyposis Coli
Biopsy
Biomarkers
Platelets
Aspirin
Cells
Platelet Count
Early Detection of Cancer
Colonic Neoplasms
Healthy Volunteers
Carcinogenesis
Immunohistochemistry
Staining and Labeling
Growth

Keywords

  • Colorectal cancer
  • Familial adenomatous polyposis
  • Thromboxane A

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance. / Li, Haitao; Liu, Kangdong; Boardman, Lisa Allyn; Zhao, Yuzhou; Wang, Lei; Sheng, Yuqiao; Oi, Naomi; Limburg, Paul John; Bode, Ann M.; Dong, Zigang.

In: EBioMedicine, Vol. 2, No. 2, 01.02.2015, p. 165-171.

Research output: Contribution to journalArticle

Li, Haitao ; Liu, Kangdong ; Boardman, Lisa Allyn ; Zhao, Yuzhou ; Wang, Lei ; Sheng, Yuqiao ; Oi, Naomi ; Limburg, Paul John ; Bode, Ann M. ; Dong, Zigang. / Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance. In: EBioMedicine. 2015 ; Vol. 2, No. 2. pp. 165-171.
@article{f0ee26b3e9204ddab3061ca20995c7d1,
title = "Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance",
abstract = "Background: Colorectal cancer (CRC) represents the third leading cause of cancer-related death in the United States. Lack of reliable biomarkers remains a critical issue for early detection of CRC. In this study, we investigated the potential predictive values of circulating prostaglandin (PG) biosynthesis in CRC risk. Methods: Profiles of circulating PG biosynthesis and platelet counts were determined in healthy subjects (n = 16), familial adenomatous polyposis (FAP) patients who were classified as regular aspirin users (n = 14) or nonusers (n = 24), and CRC patients with (n = 18) or without FAP history (n = 20). Immunohistochemistry staining was performed on biopsy samples. Results: Analysis of circulating PG biosynthesis unexpectedly revealed that CRC progression is accompanied by a pronounced elevation of circulating thromboxane A2 (TXA2) levels. When a circulating TXA2 level of 1000pg/mL was selected as a practical cutoff point, 95{\%} of CRC patients were successfully identified. Further study suggested that the TXA2 pathway is constitutively activated during colorectal tumorigenesis and required for anchorage-independent growth of colon cancer cells. Conclusions: This study established the importance of the TXA2 pathway in CRC pathophysiology, and laid the groundwork for introducing a TXA2-targeting strategy to CRC prevention, early detection and management.",
keywords = "Colorectal cancer, Familial adenomatous polyposis, Thromboxane A",
author = "Haitao Li and Kangdong Liu and Boardman, {Lisa Allyn} and Yuzhou Zhao and Lei Wang and Yuqiao Sheng and Naomi Oi and Limburg, {Paul John} and Bode, {Ann M.} and Zigang Dong",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.ebiom.2014.12.004",
language = "English (US)",
volume = "2",
pages = "165--171",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance

AU - Li, Haitao

AU - Liu, Kangdong

AU - Boardman, Lisa Allyn

AU - Zhao, Yuzhou

AU - Wang, Lei

AU - Sheng, Yuqiao

AU - Oi, Naomi

AU - Limburg, Paul John

AU - Bode, Ann M.

AU - Dong, Zigang

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: Colorectal cancer (CRC) represents the third leading cause of cancer-related death in the United States. Lack of reliable biomarkers remains a critical issue for early detection of CRC. In this study, we investigated the potential predictive values of circulating prostaglandin (PG) biosynthesis in CRC risk. Methods: Profiles of circulating PG biosynthesis and platelet counts were determined in healthy subjects (n = 16), familial adenomatous polyposis (FAP) patients who were classified as regular aspirin users (n = 14) or nonusers (n = 24), and CRC patients with (n = 18) or without FAP history (n = 20). Immunohistochemistry staining was performed on biopsy samples. Results: Analysis of circulating PG biosynthesis unexpectedly revealed that CRC progression is accompanied by a pronounced elevation of circulating thromboxane A2 (TXA2) levels. When a circulating TXA2 level of 1000pg/mL was selected as a practical cutoff point, 95% of CRC patients were successfully identified. Further study suggested that the TXA2 pathway is constitutively activated during colorectal tumorigenesis and required for anchorage-independent growth of colon cancer cells. Conclusions: This study established the importance of the TXA2 pathway in CRC pathophysiology, and laid the groundwork for introducing a TXA2-targeting strategy to CRC prevention, early detection and management.

AB - Background: Colorectal cancer (CRC) represents the third leading cause of cancer-related death in the United States. Lack of reliable biomarkers remains a critical issue for early detection of CRC. In this study, we investigated the potential predictive values of circulating prostaglandin (PG) biosynthesis in CRC risk. Methods: Profiles of circulating PG biosynthesis and platelet counts were determined in healthy subjects (n = 16), familial adenomatous polyposis (FAP) patients who were classified as regular aspirin users (n = 14) or nonusers (n = 24), and CRC patients with (n = 18) or without FAP history (n = 20). Immunohistochemistry staining was performed on biopsy samples. Results: Analysis of circulating PG biosynthesis unexpectedly revealed that CRC progression is accompanied by a pronounced elevation of circulating thromboxane A2 (TXA2) levels. When a circulating TXA2 level of 1000pg/mL was selected as a practical cutoff point, 95% of CRC patients were successfully identified. Further study suggested that the TXA2 pathway is constitutively activated during colorectal tumorigenesis and required for anchorage-independent growth of colon cancer cells. Conclusions: This study established the importance of the TXA2 pathway in CRC pathophysiology, and laid the groundwork for introducing a TXA2-targeting strategy to CRC prevention, early detection and management.

KW - Colorectal cancer

KW - Familial adenomatous polyposis

KW - Thromboxane A

UR - http://www.scopus.com/inward/record.url?scp=84943234261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943234261&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2014.12.004

DO - 10.1016/j.ebiom.2014.12.004

M3 - Article

AN - SCOPUS:84943234261

VL - 2

SP - 165

EP - 171

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

IS - 2

ER -